Effect of intravenous Vitamin C on sleep quality in hemodialysis patients

Background and Objective: Poor sleep quality is common among hemodialysis patients and can potentially predict morbidity, mortality and quality of life in these patients. On the other hand, hemodialysis patients are encountered with vitamin C deficiency. The purpose of this study was to determine the effect of intravenous vitamin C on sleep quality in hemodialysis patients. Materials and Methods: In this double blind randomized clinical trial, 60 qualified hemodialysis patients were gone under investigation in Sari a city located in North of Iran during 2010. Patients randomly allocated in two equal intervention and control groups. The main measured outcome was the Pittsburg sleep quality index (PSQI) which consists of seven components. At the end of each hemodialysis session, Intervention group received vitamin C vial (500mg/5cc) intravenously, three times a week for 8 weeks and control group received normal saline in a same way. Data were collected at pretreatment and after two months of treatment. Data were analyzed by Independent t test, Paired t test, Wilcoxon and Chi-Square tests. Results: The result indicated that the sleep quality improves significantly in vitamin C group but not in control group (P<0.001). Vitamin C caused significant improvement in subjective sleep quality, sleep latency, habitual sleep efficiency and sleep disturbances in intervention group (p<0.05). Also, Global PSQI score of intervention group had a greater improvement than control group. Moreover vitamin C caused significant improvement in subjective sleep quality, sleep latency, habitual sleep efficiency and sleep disturbances in intervention group after treatment (p<0.05). Conclusion: This study showed that intravenous vitamin C can effectively improve sleep quality in hemodialysis patients.

[1]  T. Paparrigopoulos,et al.  Sleep disturbance in haemodialysis patients is closely related to depression. , 2009, General hospital psychiatry.

[2]  K. Wu,et al.  Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  Saleh Mansour,et al.  Sleep Parameters and the Factors Affecting the Quality of Sleep in Patients Attending Selected Clinics of Rasoul-e-Akram Hospital , 2008 .

[4]  N. Levin,et al.  Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  B. Broumand,et al.  CORRELATION OF QUALITY OF SLEEP OR QUALITY OF LIFE AND SOME OF BLOOD FACTORS IN HEMODIALYSIS PATIENTS , 2008 .

[6]  S. Fereshtehnejad,et al.  CORRELATION BETWEEN SERUM C-REACTIVE PROTEIN (CRP) LEVEL AND SLEEP DISORDERS IN CHRONIC HEMODIALYSIS PATIENTS , 2007 .

[7]  S. Fukuhara,et al.  Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  N. Rashtchi,et al.  EVALUATION THE AFFECTING FACTORS IN LIPID PEROXIDATION OF HEMODIALYSIS AND RENAL TRANSPLANTED PATIENTS , 2007 .

[9]  Daniel J Buysse,et al.  Sleep quality and its correlates in the first year of dialysis. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[10]  P. Whincup,et al.  Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. , 2006, The American journal of clinical nutrition.

[11]  W. Hörl,et al.  Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. , 2005, Journal of the American Society of Nephrology : JASN.

[12]  Nader Rifai,et al.  Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. , 2004, Journal of the American College of Cardiology.

[13]  E. Lonn,et al.  Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  W. Hörl,et al.  Vitamin C in Chronic Kidney Disease and Hemodialysis Patients , 2003, Kidney and Blood Pressure Research.

[15]  K. Parker.  Sleep disturbances in dialysis patients. , 2003, Sleep medicine reviews.

[16]  M. Sabbatini,et al.  Insomnia in maintenance haemodialysis patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  M. Sevick,et al.  Correlates of Sleep Behavior among Hemodialysis Patients , 2002, American Journal of Nephrology.

[18]  P. Hanly,et al.  Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. , 2001, The New England journal of medicine.

[19]  C. Zoccali,et al.  Inflammation is associated with carotid atherosclerosis in dialysis patients , 2000, Journal of hypertension.

[20]  M. Pressman,et al.  Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  P. Kimmel.  Go to bed and get a good night's sleep: you need your rest! , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  G. Kaysen,et al.  C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  K. Iseki,et al.  Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  C. Zoccali,et al.  Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. , 1999, Journal of nephrology.

[25]  D. Tarng,et al.  Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. , 1999, Kidney international.

[26]  F. Mirershadi,et al.  BLOOD ANTIOXIDANT LEVELS AND ALTERATIONS OF SERUM CALCIUM AND PH IN HEMODIALYSIS PATIENTS , 2008 .

[27]  Z. Kashi,et al.  EFFICACY OF ORAL VERSUS INTRAVENOUS VITAMIN C ON SERUM OXALATE LEVEL IN HEMODIALYSIS PATIENTS , 2007 .

[28]  I. Nourmohammadi,et al.  THE EFFECT OF VITAMIN C SUPPLEMENTATION ON OXIDATIVE STRESS IN HEMODIALYSIS PATIENTS , 2007 .

[29]  G. Gigli,et al.  Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  Wilma M Hopman,et al.  Quality of sleep and health-related quality of life in haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.